Literature DB >> 29031076

Synthesis and evaluation of new pyridyl/pyrazinyl thiourea derivatives: Neuroprotection against amyloid-β-induced toxicity.

Jung-Eun Park1, Ahmed Elkamhawy2, Ahmed H E Hassan3, Ae Nim Pae4, Jiyoun Lee5, Sora Paik6, Beoung-Geon Park7, Eun Joo Roh8.   

Abstract

Herein, we report synthesis and evaluation of new twenty six small molecules against β amyloid (Aβ)-induced opening of mitochondrial permeability transition pore (mPTP) using JC-1 assay which measures the change of mitochondrial membrane potential (ΔΨm). The neuroprotective effect of seventeen compounds against Aβ-induced mPTP opening was superior to that of the standard Cyclosporin A (CsA). Fifteen derivatives eliciting increased green to red fluorescence percentage less than 40.0% were evaluated for their impact on ATP production, cell viability and neuroprotection against Aβ-induced neuronal cell death. Among evaluated compounds, derivatives 9w, 9r and 9k had safe profile regarding ATP production and cell viability. In addition, they exhibited significant neuroprotection (69.3, 51.8 and 48.2% respectively). Molecular modeling study using CDocker algorithm predicted plausible binding modes explaining the elicited mPTP blocking activity. Hence, this study suggests compounds 9w, 9r and 9k as leads for further development of novel therapy to Alzheimer's disease.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease (AD); Aβ-induced neurotoxicity; Cyclophilin D; Mitochondrial permeability transition pore (mPTP); Molecular docking; Thiourea; β-Amyloid peptide (Aβ)

Mesh:

Substances:

Year:  2017        PMID: 29031076     DOI: 10.1016/j.ejmech.2017.09.043

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

1.  2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation.

Authors:  Mohamed H Elsherbeny; Usama M Ammar; Magda H Abdellattif; Mohammed A S Abourehab; Ahmed Abdeen; Samah F Ibrahim; Doaa Abdelrahaman; Wessam Mady; Eun Joo Roh; Ahmed Elkamhawy
Journal:  Life (Basel)       Date:  2022-06-10

2.  Synthesis, X-ray crystal structure elucidation and Hirshfeld surface analysis of N-((4-(1H-benzo[d]imidazole-2-yl)phenyl)carbamothioyl)benzamide: investigations for elastase inhibition, antioxidant and DNA binding potentials for biological applications.

Authors:  Nasima Arshad; Mamoona Rafiq; Rabail Ujan; Aamer Saeed; Shahid I Farooqi; Fouzia Perveen; Pervaiz Ali Channar; Saba Ashraf; Qamar Abbas; Ashfaq Ahmed; Tuncer Hokelek; Manpreet Kaur; Jerry P Jasinski
Journal:  RSC Adv       Date:  2020-06-02       Impact factor: 4.036

Review 3.  Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention.

Authors:  Thomas Briston; Amy R Hicks
Journal:  Biochem Soc Trans       Date:  2018-07-09       Impact factor: 5.407

Review 4.  The Mitochondrial Permeability Transition in Mitochondrial Disorders.

Authors:  Justina Šileikytė; Michael Forte
Journal:  Oxid Med Cell Longev       Date:  2019-05-05       Impact factor: 6.543

5.  4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro, and in-silico biological studies.

Authors:  Hossam Nada; Ahmed Elkamhawy; Magda H Abdellattif; Andrea Angeli; Chang Hoon Lee; Claudiu T Supuran; Kyeong Lee
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

6.  Identification of Novel and Potent Indole-Based Benzenesulfonamides as Selective Human Carbonic Anhydrase II Inhibitors: Design, Synthesis, In Vitro, and In Silico Studies.

Authors:  Ahmed Elkamhawy; Jiyu Woo; Hossam Nada; Andrea Angeli; Tarek M Bedair; Claudiu T Supuran; Kyeong Lee
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

7.  Sulfur-containing therapeutics in the treatment of Alzheimer's disease.

Authors:  Haizhou Zhu; Venkateshwara Dronamraju; Wei Xie; Swati S More
Journal:  Med Chem Res       Date:  2021-01-15       Impact factor: 1.965

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.